Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Nanchang UniversityActive in the last 2 years

Chen Huan Luo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2719-244X; OpenAlex author ID A5101481371. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 6

  1. Deubiquitinase PSMD7 facilitates pancreatic cancer progression through activating Nocth1 pathway via modifying SOX2 degradation. Co-author DOI 10.1186/s13578-024-01213-9↗
  2. MicroRNA 211-5p inhibits cancer cell proliferation and migration in pancreatic cancer by targeting BMP2. First author DOI 10.18632/aging.205320↗
  3. FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression. Co-author DOI 10.1038/s41419-022-04960-0↗
  4. Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fonc.2022.799475↗
  5. LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway. Co-author DOI 10.1016/j.omtn.2021.08.024↗
  6. Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients. Co-author DOI 10.2147/ott.s275649↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jinfeng Zhu · 5 shared papers, 2020–2024 · strength 0.76
  2. Rongfa Yuan · 2 shared papers, 2022–2024 · strength 0.34
  3. Leifeng Chen · 2 shared papers, 2022–2024 · strength 0.34
  4. Jiefeng Zhao · 2 shared papers, 2020–2022 · strength 0.24
  5. Fanqin Bu · 2 shared papers, 2020–2022 · strength 0.24
  6. Jianbing Wu · 1 shared paper, 2023 · strength 0.20
  7. Dan Li · 1 shared paper, 2023 · strength 0.20
  8. Hongliang Luo · 1 shared paper, 2022 · strength 0.16
  9. Qian Huang · 1 shared paper, 2022 · strength 0.16
  10. Zhengming Zhu · 1 shared paper, 2021 · strength 0.16
  11. Xin Yu · 1 shared paper, 2022 · strength 0.13
  12. Jun Huang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.